{"id":2021,"date":"2025-08-07T10:39:12","date_gmt":"2025-08-07T13:39:12","guid":{"rendered":"https:\/\/heloisahsalomao.com.br\/?p=1630"},"modified":"2025-08-07T10:39:12","modified_gmt":"2025-08-07T13:39:12","slug":"acesso-pos-estudo-ao-medicamento-experimental-o-que-diz-a-pesquisa-clinica","status":"publish","type":"post","link":"https:\/\/heloisahsalomao.com.br\/?p=2021","title":{"rendered":"Acesso p\u00f3s-estudo ao medicamento experimental: o que diz a pesquisa cl\u00ednica?"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">O desenvolvimento de um novo medicamento envolve anos de pesquisa, testes rigorosos e, sobretudo, a participa\u00e7\u00e3o volunt\u00e1ria de pessoas em estudos cl\u00ednicos. Mas o que acontece com esses participantes quando o estudo termina? Eles continuam recebendo o tratamento que ajudaram a testar?<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Essa pergunta nos leva a um tema essencial e sens\u00edvel da \u00e9tica em pesquisa: o <\/span><b>acesso p\u00f3s-estudo ao medicamento experimental<\/b><span style=\"font-weight: 400;\">.<\/span><\/p>\n<h2><b>O que \u00e9 o acesso p\u00f3s-estudo?<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">O acesso p\u00f3s-estudo, tamb\u00e9m chamado de <\/span><b>continuidade do tratamento<\/b><span style=\"font-weight: 400;\">, \u00e9 a <\/span><b>disponibiliza\u00e7\u00e3o do medicamento experimental para o participante mesmo ap\u00f3s o encerramento do ensaio cl\u00ednico<\/b><span style=\"font-weight: 400;\">, especialmente nos casos em que ele obteve benef\u00edcio comprovado durante o estudo e n\u00e3o h\u00e1 alternativa terap\u00eautica equivalente dispon\u00edvel.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Esse acesso \u00e9 uma forma de proteger o participante de riscos decorrentes da interrup\u00e7\u00e3o abrupta do tratamento e reconhecer sua contribui\u00e7\u00e3o para o avan\u00e7o da ci\u00eancia.<\/span><\/p>\n<h2><b>Por que isso \u00e9 importante?<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Imagine uma pessoa com uma doen\u00e7a grave ou rara que participa de um estudo cl\u00ednico e responde bem ao tratamento experimental. Se o estudo termina e ela n\u00e3o tem mais acesso ao medicamento, pode haver <\/span><b>preju\u00edzo direto \u00e0 sua sa\u00fade<\/b><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Al\u00e9m disso, a falta de acesso pode gerar <\/span><b>inseguran\u00e7a e desconfian\u00e7a<\/b><span style=\"font-weight: 400;\"> quanto \u00e0 \u00e9tica da pesquisa, principalmente em popula\u00e7\u00f5es mais vulner\u00e1veis.<\/span><\/p>\n<h2><b>O que diz a legisla\u00e7\u00e3o no Brasil?<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">A <\/span><b>Resolu\u00e7\u00e3o RDC n\u00ba 38\/2013 da Anvisa<\/b><span style=\"font-weight: 400;\"> trata especificamente do fornecimento de medicamento p\u00f3s-estudo. Segundo o artigo 6\u00ba dessa norma, o patrocinador \u00e9 <\/span><b>respons\u00e1vel por garantir o acesso ao medicamento experimental aos participantes ap\u00f3s o t\u00e9rmino do estudo<\/b><span style=\"font-weight: 400;\"> quando se verificarem, cumulativamente, os seguintes crit\u00e9rios:<\/span><\/p>\n<ol>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Necessidade m\u00e9dica comprovada<\/b><b>\n<p><\/b><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Benef\u00edcio cl\u00ednico demonstrado durante o estudo<\/b><b>\n<p><\/b><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Aus\u00eancia de alternativa terap\u00eautica satisfat\u00f3ria no mercado nacional<\/b><b>\n<p><\/b><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Avalia\u00e7\u00e3o m\u00e9dica que justifique a continuidade<\/b><b>\n<p><\/b><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Decis\u00e3o documentada e justificada pelo investigador e patrocinador<\/b><b>\n<p><\/b><\/li>\n<\/ol>\n<p><span style=\"font-weight: 400;\">O fornecimento deve continuar <\/span><b>enquanto persistir a necessidade cl\u00ednica<\/b><span style=\"font-weight: 400;\">, salvo se a Anvisa autorizar outra conduta.<\/span><\/p>\n<h2><b>E o Comit\u00ea de \u00c9tica?<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Os <\/span><b>Comit\u00eas de \u00c9tica em Pesquisa (CEP)<\/b><span style=\"font-weight: 400;\"> e a <\/span><b>CONEP<\/b><span style=\"font-weight: 400;\"> tamb\u00e9m avaliam essa quest\u00e3o. A continuidade do tratamento deve estar prevista no <\/span><b>protocolo de pesquisa<\/b><span style=\"font-weight: 400;\"> e no <\/span><b>Termo de Consentimento Livre e Esclarecido (TCLE)<\/b><span style=\"font-weight: 400;\">, deixando claro ao participante em que condi\u00e7\u00f5es ele poder\u00e1 continuar recebendo o medicamento.<\/span><\/p>\n<h2><b>H\u00e1 limita\u00e7\u00f5es ou exce\u00e7\u00f5es?<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Sim. A nova Lei da Pesquisa Cl\u00ednica (Lei n\u00ba 14.874\/2024) estabelece que o fornecimento gratuito do medicamento experimental no p\u00f3s-estudo pode ser interrompido, desde que haja justificativa documentada e submetida ao Comit\u00ea de \u00c9tica (CEP), nas seguintes situa\u00e7\u00f5es:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Decis\u00e3o do participante de interromper o uso, ou, se ele n\u00e3o puder expressar sua vontade, conforme crit\u00e9rios legais espec\u00edficos.<\/span><span style=\"font-weight: 400;\">\n<p><\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Cura da doen\u00e7a ou aparecimento de uma alternativa terap\u00eautica satisfat\u00f3ria, devidamente registrada no Brasil.<\/span><span style=\"font-weight: 400;\">\n<p><\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Aus\u00eancia de benef\u00edcio cl\u00ednico com o uso continuado do medicamento, considerando a rela\u00e7\u00e3o risco-benef\u00edcio fora do contexto do estudo.<\/span><span style=\"font-weight: 400;\">\n<p><\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Ocorr\u00eancia de rea\u00e7\u00f5es adversas que, a crit\u00e9rio do pesquisador, inviabilizem a continuidade do tratamento.<\/span><span style=\"font-weight: 400;\">\n<p><\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Impossibilidade t\u00e9cnica ou de seguran\u00e7a para obter ou fabricar o medicamento, desde que o patrocinador ofere\u00e7a uma alternativa equivalente ou superior.<\/span><span style=\"font-weight: 400;\">\n<p><\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Cinco anos ap\u00f3s a entrada comercial do medicamento no Brasil, o fornecimento gratuito pode ser encerrado.<\/span><span style=\"font-weight: 400;\">\n<p><\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Disponibilidade do medicamento no SUS, tornando desnecess\u00e1rio o fornecimento especial.<\/span><span style=\"font-weight: 400;\">\n<p><\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Essas condi\u00e7\u00f5es refor\u00e7am que, embora o acesso p\u00f3s-estudo seja um direito \u00e9tico, sua continuidade depende de crit\u00e9rios cl\u00ednicos, regulat\u00f3rios e de viabilidade t\u00e9cnica, sempre com supervis\u00e3o \u00e9tica adequada.<\/span><\/p>\n<h2><b>Um direito \u00e9tico, n\u00e3o um benef\u00edcio opcional<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">A continuidade do acesso ao medicamento ap\u00f3s o estudo n\u00e3o deve ser vista como um \u201cb\u00f4nus\u201d, mas como uma <\/span><b>responsabilidade \u00e9tica<\/b><span style=\"font-weight: 400;\"> de todos os envolvidos na pesquisa cl\u00ednica \u2013 patrocinadores, pesquisadores e reguladores.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Essa pr\u00e1tica refor\u00e7a o compromisso com os <\/span><b>direitos dos participantes<\/b><span style=\"font-weight: 400;\">, valorizando sua contribui\u00e7\u00e3o para o avan\u00e7o da medicina e garantindo que a ci\u00eancia caminhe lado a lado com a equidade e o cuidado.<\/span><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>O desenvolvimento de um novo medicamento envolve anos de pesquisa, testes rigorosos e, sobretudo, a participa\u00e7\u00e3o volunt\u00e1ria de pessoas em estudos cl\u00ednicos. Mas o que acontece com esses participantes quando o estudo termina? Eles continuam recebendo o tratamento que ajudaram a testar? Essa pergunta nos leva a um tema essencial e sens\u00edvel da \u00e9tica em [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1632,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10,12,13,14],"tags":[],"class_list":["post-2021","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-leigos","category-pesquisa-clinica","category-profissionais","category-sistema-etico"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Acesso p\u00f3s-estudo ao medicamento experimental: o que diz a pesquisa cl\u00ednica? - Heloisa Salom\u00e3o<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Acesso p\u00f3s-estudo ao medicamento experimental: o que diz a pesquisa cl\u00ednica? - Heloisa Salom\u00e3o\" \/>\n<meta property=\"og:description\" content=\"O desenvolvimento de um novo medicamento envolve anos de pesquisa, testes rigorosos e, sobretudo, a participa\u00e7\u00e3o volunt\u00e1ria de pessoas em estudos cl\u00ednicos. Mas o que acontece com esses participantes quando o estudo termina? Eles continuam recebendo o tratamento que ajudaram a testar? Essa pergunta nos leva a um tema essencial e sens\u00edvel da \u00e9tica em [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/heloisahsalomao.com.br\/?p=2021\" \/>\n<meta property=\"og:site_name\" content=\"Heloisa Salom\u00e3o\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-07T13:39:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/heloisahsalomao.com.br\/wp-content\/uploads\/2025\/08\/Acesso-pos-estudo-ao-medicamento-experimental.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"rezeta\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"rezeta\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/?p=2021#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/?p=2021\"},\"author\":{\"name\":\"rezeta\",\"@id\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/#\\\/schema\\\/person\\\/75e87567608819ff2065d37128946b80\"},\"headline\":\"Acesso p\u00f3s-estudo ao medicamento experimental: o que diz a pesquisa cl\u00ednica?\",\"datePublished\":\"2025-08-07T13:39:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/?p=2021\"},\"wordCount\":708,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/?p=2021#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Acesso-pos-estudo-ao-medicamento-experimental.png\",\"articleSection\":[\"Leigos\",\"Pesquisa Cl\u00ednica\",\"Profissionais\",\"Sistema \u00c9tico\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/heloisahsalomao.com.br\\\/?p=2021#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/?p=2021\",\"url\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/?p=2021\",\"name\":\"Acesso p\u00f3s-estudo ao medicamento experimental: o que diz a pesquisa cl\u00ednica? - Heloisa Salom\u00e3o\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/?p=2021#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/?p=2021#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Acesso-pos-estudo-ao-medicamento-experimental.png\",\"datePublished\":\"2025-08-07T13:39:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/?p=2021#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/heloisahsalomao.com.br\\\/?p=2021\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/?p=2021#primaryimage\",\"url\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Acesso-pos-estudo-ao-medicamento-experimental.png\",\"contentUrl\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Acesso-pos-estudo-ao-medicamento-experimental.png\",\"width\":1024,\"height\":1024},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/?p=2021#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Acesso p\u00f3s-estudo ao medicamento experimental: o que diz a pesquisa cl\u00ednica?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/#website\",\"url\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/\",\"name\":\"Heloisa Salom\u00e3o - Blog de Pesquisa Cl\u00ednica\",\"description\":\"Blog de Pesquisa Cl\u00ednica\",\"publisher\":{\"@id\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/#organization\",\"name\":\"Heloisa Salom\u00e3o\",\"url\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/cropped-Elegant-White-and-Black-Real-Estate-Agent-Logo.png\",\"contentUrl\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/cropped-Elegant-White-and-Black-Real-Estate-Agent-Logo.png\",\"width\":355,\"height\":197,\"caption\":\"Heloisa Salom\u00e3o\"},\"image\":{\"@id\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.instagram.com\\\/regpesquisaclinicabr\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/#\\\/schema\\\/person\\\/75e87567608819ff2065d37128946b80\",\"name\":\"rezeta\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/79c25b898200b4ddd79ea5bbc106522dd63e1512532cd3abdfcc41cb640390a3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/79c25b898200b4ddd79ea5bbc106522dd63e1512532cd3abdfcc41cb640390a3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/79c25b898200b4ddd79ea5bbc106522dd63e1512532cd3abdfcc41cb640390a3?s=96&d=mm&r=g\",\"caption\":\"rezeta\"},\"sameAs\":[\"https:\\\/\\\/heloisahsalomao.com.br\"],\"url\":\"https:\\\/\\\/heloisahsalomao.com.br\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Acesso p\u00f3s-estudo ao medicamento experimental: o que diz a pesquisa cl\u00ednica? - Heloisa Salom\u00e3o","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"pt_BR","og_type":"article","og_title":"Acesso p\u00f3s-estudo ao medicamento experimental: o que diz a pesquisa cl\u00ednica? - Heloisa Salom\u00e3o","og_description":"O desenvolvimento de um novo medicamento envolve anos de pesquisa, testes rigorosos e, sobretudo, a participa\u00e7\u00e3o volunt\u00e1ria de pessoas em estudos cl\u00ednicos. Mas o que acontece com esses participantes quando o estudo termina? Eles continuam recebendo o tratamento que ajudaram a testar? Essa pergunta nos leva a um tema essencial e sens\u00edvel da \u00e9tica em [&hellip;]","og_url":"https:\/\/heloisahsalomao.com.br\/?p=2021","og_site_name":"Heloisa Salom\u00e3o","article_published_time":"2025-08-07T13:39:12+00:00","og_image":[{"width":1024,"height":1024,"url":"https:\/\/heloisahsalomao.com.br\/wp-content\/uploads\/2025\/08\/Acesso-pos-estudo-ao-medicamento-experimental.png","type":"image\/png"}],"author":"rezeta","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"rezeta","Est. tempo de leitura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/heloisahsalomao.com.br\/?p=2021#article","isPartOf":{"@id":"https:\/\/heloisahsalomao.com.br\/?p=2021"},"author":{"name":"rezeta","@id":"https:\/\/heloisahsalomao.com.br\/#\/schema\/person\/75e87567608819ff2065d37128946b80"},"headline":"Acesso p\u00f3s-estudo ao medicamento experimental: o que diz a pesquisa cl\u00ednica?","datePublished":"2025-08-07T13:39:12+00:00","mainEntityOfPage":{"@id":"https:\/\/heloisahsalomao.com.br\/?p=2021"},"wordCount":708,"commentCount":0,"publisher":{"@id":"https:\/\/heloisahsalomao.com.br\/#organization"},"image":{"@id":"https:\/\/heloisahsalomao.com.br\/?p=2021#primaryimage"},"thumbnailUrl":"https:\/\/heloisahsalomao.com.br\/wp-content\/uploads\/2025\/08\/Acesso-pos-estudo-ao-medicamento-experimental.png","articleSection":["Leigos","Pesquisa Cl\u00ednica","Profissionais","Sistema \u00c9tico"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/heloisahsalomao.com.br\/?p=2021#respond"]}]},{"@type":"WebPage","@id":"https:\/\/heloisahsalomao.com.br\/?p=2021","url":"https:\/\/heloisahsalomao.com.br\/?p=2021","name":"Acesso p\u00f3s-estudo ao medicamento experimental: o que diz a pesquisa cl\u00ednica? - Heloisa Salom\u00e3o","isPartOf":{"@id":"https:\/\/heloisahsalomao.com.br\/#website"},"primaryImageOfPage":{"@id":"https:\/\/heloisahsalomao.com.br\/?p=2021#primaryimage"},"image":{"@id":"https:\/\/heloisahsalomao.com.br\/?p=2021#primaryimage"},"thumbnailUrl":"https:\/\/heloisahsalomao.com.br\/wp-content\/uploads\/2025\/08\/Acesso-pos-estudo-ao-medicamento-experimental.png","datePublished":"2025-08-07T13:39:12+00:00","breadcrumb":{"@id":"https:\/\/heloisahsalomao.com.br\/?p=2021#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/heloisahsalomao.com.br\/?p=2021"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/heloisahsalomao.com.br\/?p=2021#primaryimage","url":"https:\/\/heloisahsalomao.com.br\/wp-content\/uploads\/2025\/08\/Acesso-pos-estudo-ao-medicamento-experimental.png","contentUrl":"https:\/\/heloisahsalomao.com.br\/wp-content\/uploads\/2025\/08\/Acesso-pos-estudo-ao-medicamento-experimental.png","width":1024,"height":1024},{"@type":"BreadcrumbList","@id":"https:\/\/heloisahsalomao.com.br\/?p=2021#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/heloisahsalomao.com.br\/"},{"@type":"ListItem","position":2,"name":"Acesso p\u00f3s-estudo ao medicamento experimental: o que diz a pesquisa cl\u00ednica?"}]},{"@type":"WebSite","@id":"https:\/\/heloisahsalomao.com.br\/#website","url":"https:\/\/heloisahsalomao.com.br\/","name":"Heloisa Salom\u00e3o - Blog de Pesquisa Cl\u00ednica","description":"Blog de Pesquisa Cl\u00ednica","publisher":{"@id":"https:\/\/heloisahsalomao.com.br\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/heloisahsalomao.com.br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/heloisahsalomao.com.br\/#organization","name":"Heloisa Salom\u00e3o","url":"https:\/\/heloisahsalomao.com.br\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/heloisahsalomao.com.br\/#\/schema\/logo\/image\/","url":"https:\/\/heloisahsalomao.com.br\/wp-content\/uploads\/2026\/07\/cropped-Elegant-White-and-Black-Real-Estate-Agent-Logo.png","contentUrl":"https:\/\/heloisahsalomao.com.br\/wp-content\/uploads\/2026\/07\/cropped-Elegant-White-and-Black-Real-Estate-Agent-Logo.png","width":355,"height":197,"caption":"Heloisa Salom\u00e3o"},"image":{"@id":"https:\/\/heloisahsalomao.com.br\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.instagram.com\/regpesquisaclinicabr\/"]},{"@type":"Person","@id":"https:\/\/heloisahsalomao.com.br\/#\/schema\/person\/75e87567608819ff2065d37128946b80","name":"rezeta","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/79c25b898200b4ddd79ea5bbc106522dd63e1512532cd3abdfcc41cb640390a3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/79c25b898200b4ddd79ea5bbc106522dd63e1512532cd3abdfcc41cb640390a3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/79c25b898200b4ddd79ea5bbc106522dd63e1512532cd3abdfcc41cb640390a3?s=96&d=mm&r=g","caption":"rezeta"},"sameAs":["https:\/\/heloisahsalomao.com.br"],"url":"https:\/\/heloisahsalomao.com.br\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/heloisahsalomao.com.br\/index.php?rest_route=\/wp\/v2\/posts\/2021","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/heloisahsalomao.com.br\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/heloisahsalomao.com.br\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/heloisahsalomao.com.br\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/heloisahsalomao.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2021"}],"version-history":[{"count":0,"href":"https:\/\/heloisahsalomao.com.br\/index.php?rest_route=\/wp\/v2\/posts\/2021\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/heloisahsalomao.com.br\/index.php?rest_route=\/wp\/v2\/media\/1632"}],"wp:attachment":[{"href":"https:\/\/heloisahsalomao.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2021"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/heloisahsalomao.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2021"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/heloisahsalomao.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2021"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}